1:40 PM - 1:48 PM
○Kentaro YAMATO1, Tatsuo MARUMOTO1, Ken INADA2, Minori ENOMOTO3, Masahiro TAKESHIMA4, Kazuo MISHIMA 4 (1. Japan Medical Office, Takeda Pharmaceutical Company Limited, 2. Department of Psychiatry, Tokyo Women's Medical University, 3. Department of Medical Technology, School of Health Sciences, Tokyo University of Technology, 4. Department of Neuropsychiatry, Akita University Graduate School of Medicine)